BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25712485)

  • 1. Cells for tissue engineering of cardiac valves.
    Jana S; Tranquillo RT; Lerman A
    J Tissue Eng Regen Med; 2016 Oct; 10(10):804-824. PubMed ID: 25712485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
    Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
    Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
    Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
    J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
    Weber B; Zeisberger SM; Hoerstrup SP
    Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomechanical conditioning of tissue engineered heart valves: Too much of a good thing?
    Parvin Nejad S; Blaser MC; Santerre JP; Caldarone CA; Simmons CA
    Adv Drug Deliv Rev; 2016 Jan; 96():161-75. PubMed ID: 26555371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
    Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology.
    Sewell-Loftin MK; Chun YW; Khademhosseini A; Merryman WD
    J Cardiovasc Transl Res; 2011 Oct; 4(5):658-71. PubMed ID: 21751069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering.
    Taylor PM; Allen SP; Dreger SA; Yacoub MH
    J Heart Valve Dis; 2002 May; 11(3):298-306; discussion 306-7. PubMed ID: 12056719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete Static Repopulation of Decellularized Porcine Tissues for Heart Valve Engineering: An in vitro Study.
    Roosens A; Asadian M; De Geyter N; Somers P; Cornelissen R
    Cells Tissues Organs; 2017; 204(5-6):270-282. PubMed ID: 29131080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart valve and myocardial tissue engineering].
    Cebotari S; Tudorache I; Schilling T; Haverich A
    Herz; 2010 Aug; 35(5):334-41. PubMed ID: 20631970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart valve tissue engineering.
    Vesely I
    Circ Res; 2005 Oct; 97(8):743-55. PubMed ID: 16224074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of: application of synthetic scaffold in tissue engineering heart valves.
    Fallahiarezoudar E; Ahmadipourroudposht M; Idris A; Mohd Yusof N
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():556-65. PubMed ID: 25579957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
    Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
    Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioengineered living cardiac and venous valve replacements: current status and future prospects.
    Kehl D; Weber B; Hoerstrup SP
    Cardiovasc Pathol; 2016; 25(4):300-305. PubMed ID: 27167776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tissue engineering for heart valves and vascular grafts].
    Teebken OE; Wilhelmi M; Haverich A
    Chirurg; 2005 May; 76(5):453-66. PubMed ID: 15841408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute.
    Breuer CK; Mettler BA; Anthony T; Sales VL; Schoen FJ; Mayer JE
    Tissue Eng; 2004; 10(11-12):1725-36. PubMed ID: 15684681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication and In Vitro Characterization of a Tissue Engineered PCL-PLLA Heart Valve.
    Hasan A; Soliman S; El Hajj F; Tseng YT; Yalcin HC; Marei HE
    Sci Rep; 2018 May; 8(1):8187. PubMed ID: 29844329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tissue engineering of heart valves: new opportunities and challenges].
    Bobylev DO; Chebotar' S; Tudorake I; Khaverikh A
    Kardiologiia; 2011; 51(12):50-6. PubMed ID: 22304317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaffolds for tissue engineering of cardiac valves.
    Jana S; Tefft BJ; Spoon DB; Simari RD
    Acta Biomater; 2014 Jul; 10(7):2877-93. PubMed ID: 24675108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
    Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
    J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.